Xero Ltd
OTC:XROLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
Xero Ltd
OTC:XROLF
|
NZ |
|
Opendoor Technologies Inc
NASDAQ:OPEN
|
US |
|
Genesis Healthcare Inc
OTC:GENN
|
US |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
SA |
|
V
|
Village Farms International Inc
NASDAQ:VFF
|
CA |
|
Hanover Insurance Group Inc
NYSE:THG
|
US |
|
O
|
Oculis Holding AG
NASDAQ:OCS
|
CH |
|
D
|
Do & Co AG
VSE:DOC
|
AT |
|
Bank Rakyat Indonesia (Persero) Tbk PT
OTC:BKRKY
|
ID |
|
Big Lots Inc
NYSE:BIG
|
US |
|
Idex Biometrics ASA
OSE:IDEX
|
NO |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
US |
|
T
|
Techbond Group Bhd
KLSE:TECHBND
|
MY |
Wall Street
Price Targets
XROLF Price Targets Summary
Xero Ltd
According to Wall Street analysts, the average 1-year price target for
XROLF
is 114.11 USD
with a low forecast of 58.1 USD and a high forecast of 170.77 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is XROLF's stock price target?
Price Target
114.11
USD
According to Wall Street analysts, the average 1-year price target for
XROLF
is 114.11 USD
with a low forecast of 58.1 USD and a high forecast of 170.77 USD.
What is Xero Ltd's Revenue forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Xero Ltd's revenue is
43%.
The projected
CAGR
for the next 4 years is
22%.
What is Xero Ltd's Operating Income forecast?
Projected CAGR
28%
The
compound annual growth rate
of Xero Ltd's operating income for the next 4 years is
28%.
What is Xero Ltd's Net Income forecast?
Projected CAGR
31%
The
compound annual growth rate
of Xero Ltd's net income for the next 4 years is
31%.
